358x Filetype PPTX File size 0.53 MB Source: renaissance.stonybrookmedicine.edu
Categorizing CDI – Testing and Detection
Beginning January 2, 2020, Stony Brook will be utilizing a two-step testing algorithm
including a PCR (polymerase chain reaction) and EIA (enzyme immunoassay) for all
Inpatient and ED locations.
• The PCR test is highly sensitive and specific test for toxigenic genes. It cannot
distinguish between active infection and asymptomatic carriage
• The EIA test has a low sensitivity, but high specificity for the toxin production.
It helps to determine an active infection or asymptomatic carriage
The EIA test will result after a +PCR result in PowerChart
Utilizing both PCR and EIA testing helps clinicians determine an appropriate treatment
plan based on active infections or asymptomatic carriage.
When to Reflex?
PCR + EIA Reflex Testing
How to Interpret your CD Test Results
PCR EIA Interpretation Treatment Recommendation Isolation
Result Result
Positive Positive Toxigenic C.difficile • Treat as CDI (refer to C.diff PowerPlan). • Yes
detected, Suggestive • Stop acid suppression medications and
of active infection concomitant antibiotics if medically safe.
Negative Negative C.difficile not • No treatment for CDI recommended. • No
detected • Evaluate for other causes of diarrhea.
Positive Negative Suggestive of • Treatment decision should be individualized. • Yes,
Colonization with • Consider treatment in those with severe, continuation
C.difficile non-resolving, or otherwise unexplained to be
diarrhea strongly suggestive of CDI assessed by
HED
Positive Pending C. Difficile detected, • Treatment decision should be individualized. • Yes
active infection to be
determined
no reviews yet
Please Login to review.